Edwards Pradenas

Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses

Natalia Ortega, Marta Ribes, Marta Vidal et al. · Nature Communications · 2021 · 186 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes

Edwards Pradenas, Benjamin Trinité, Víctor Urrea et al. · Med · 2021 · 125 citations · Full text

Pharmacy, Immunology, Infectious Diseases +13

SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity

Benjamin Trinité, Ferran Tarrés-Freixas, Jordi Rodon et al. · Scientific Reports · 2021 · 123 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial

Andrea Alemany, Pere Millat-Martínez, Marc Corbacho‐Monné et al. · The Lancet Respiratory Medicine · 2022 · 85 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +10

Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In Vitro

Jordana Muñoz‐Basagoiti, Daniel Perez‐Zsolt, Rubén León et al. · Journal of Dental Research · 2021 · 68 citations

Life Sciences, Infectious Diseases, Molecular Virology +15